Table 1.
Genetic and clinical characteristics of patients with FHL
Patient | Sex | Age | PRF1 | UNC13D | STX11 | NK function in lytic units* | Perforin MCF NK cells† |
---|---|---|---|---|---|---|---|
P33 | Female | 2 months | 50delT + Q481P | ND | ND | 0.0 | 0.0 |
P35 | Male | 7 years | hV50M | ND | ND | 9.2 | 57 |
P59 | Male | 3 months | h50delT | ND | ND | 0.0 | 0.0 |
P1002 | Female | 9 years | wt | wt | wt | 57.4 | 501 |
P101 | Male | 6 years | wt | wt | wt | 15.3 | 440 |
P66 | Female | 15 years | wt | wt | wt | 0.1 | 100 |
P76 | Male | 5 years | wt | wt | wt | 13.3 | 634 |
P92 | Female | 1 months | wt | 1993(−2) a > c + wt | wt | 1.0 | 552 |
P98 | Male | 1 months | wt | wt | wt | 0.0 | 781 |
P94 | Male | 5 years | wt | wt | wt | 0.0 | 181 |
P96 | Male | 16 months | wt | wt | wt | 7.4 | 404 |
Normal controls: 5-35 lytic units (mean, 11.3 lytic units).
Normal controls: 244-502 MCF.